AMGEN INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $36.8 | $33.4 | $28.2 | $26.3 | $26.0 |
| Operating income | $9.1 | $7.3 | $7.9 | $9.6 | $7.6 |
| Net income | $7.7 | $4.1 | $6.7 | $6.6 | $5.9 |
| Cash Flow Statement | |||||
| Free cash flow | $8.1 | $10.4 | $7.4 | $8.8 | $8.4 |
| Dividends | $5.1 | $4.8 | $4.6 | $4.2 | $4.0 |
| Share repurchases | $0.0 | $0.2 | $0.0 | $6.4 | $5.0 |
Shares outstanding 540.6M · Free float 99.8%
Annual filing data through FY ended December 31, 2025; float as of September 19, 2026.